# Corning Incorporated – Consensus ‘buy’ rating and -6.7% Downside Potential

- Link: https://www.directorstalkinterviews.com/corning-incorporated-consensus-buy-rating-and-6.7-downside-potential/4121165045
- Published: 2024-07-15T12:32:18+01:00
- Author: Charlotte Edwards

**Corning Incorporated** which can be found using ticker (GLW) now have 13 market
analysts covering the stock. The analyst consensus now points to a rating of ‘buy’.
The target price High/Low ranges between $50.00 and $33.50 suggesting an average
Analsyt target price of $42.04. Given that the stocks previous close was at $45.05
this indicates there is a potential downside of -6.7%. The 50 day moving average
now sits at $37.54 and the 200 moving average now moves to $32.21. The company has
a market capitalization of 39.08B. The stock price for Occidental Petroleum Corporation
is $45.62 USD

 The potential market cap would be $36,467,910,203 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 63.36, revenue per share of $14.57
and a 2.85% return on assets.

Corning Incorporated is a materials science technology and innovation company. The
Company operates through five segments: Optical Communications, Display Technologies,
Specialty Materials, Environmental Technologies and Life Sciences. The Optical Communications
segment manufactures carrier network and enterprise network components for the telecommunications
industry. The Display Technologies segment manufactures glass substrates for flat
panel liquid crystal displays and other high-performance display panels. Its Specialty
Materials segment is engaged in manufacturing products that provide material formulations
for glass, glass ceramics and fluoride crystals to meet demand for customer needs.
Its Environmental Technologies segment manufactures ceramic substrates and filters
for emission control systems. Its Life Sciences segment manufactures glass and plastic
labware, equipment, media, serum and reagents enabling workflow solutions for drug
discovery and bioproduction.

Share on: